Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 232

1.

Cationic Copolymer-Chaperoned 2D-3D Reversible Conversion of Lipid Membranes.

Shimada N, Kinoshita H, Umegae T, Azumai S, Kume N, Ochiai T, Takenaka T, Sakamoto W, Yamada T, Furuta T, Masuda T, Sakurai M, Higuchi H, Maruyama A.

Adv Mater. 2019 Nov;31(44):e1904032. doi: 10.1002/adma.201904032. Epub 2019 Sep 24.

PMID:
31550402
2.

Designing Archetype Models for Each Step of Workflow in Medication.

Kobayashi S, Kume N, Yoshihara H.

Stud Health Technol Inform. 2019 Aug 21;264:1702-1703. doi: 10.3233/SHTI190605.

PMID:
31438301
3.

Original Laboratory Test Code Mapping System Using Test Result Data on Electronic Health Record.

Kume N, Suzuki K, Kobayashi S, Yoshihara H, Araki K.

Stud Health Technol Inform. 2019 Aug 21;264:1518-1519. doi: 10.3233/SHTI190513.

PMID:
31438210
4.

Governance and Sustainability of an Open Source Electronic Health Record: An Interpretive Case Study of OpenDolphin in Japan.

Poba-Nzaou P, Kume N, Kobayashi S.

Stud Health Technol Inform. 2019 Aug 21;264:739-743. doi: 10.3233/SHTI190321.

PMID:
31438022
5.

The prevalence and disease burden of severe eosinophilic asthma in Japan.

Nagasaki T, Sato K, Kume N, Oguma T, Sunadome H, Ito I, Izuhara Y, Okamoto K, Kobayashi S, Ohno T, Mizukami A, Kobayashi A, Kaise T, Kuroda T, Mishima M, Matsumoto H.

J Asthma. 2019 Nov;56(11):1147-1158. doi: 10.1080/02770903.2018.1534967. Epub 2019 Mar 1.

PMID:
30822174
6.

Effects of Ramelteon and Other Sleep-Promoting Drugs on Serum Low-Density Lipoprotein and Non-high-density Lipoprotein Cholesterol: A Retrospective Comparative Pilot Study.

Torii H, Shimizu R, Tanizaki Y, Omiya Y, Yamamoto M, Kamiike S, Yasuda D, Hiraoka Y, Hashida T, Kume N.

Biol Pharm Bull. 2018;41(12):1778-1790. doi: 10.1248/bpb.b18-00411.

7.

AGING AND HEALTH TECHNOLOGY ASSESSMENT: AN IDEA WHOSE TIME HAS COME.

Juzwishin D, McNeil H, Ahn J, Chen Y, Cicchetti A, Kume N, Brooks L, Stolee P.

Int J Technol Assess Health Care. 2018 Jan;34(5):442-446. doi: 10.1017/S0266462318000600.

PMID:
30479246
8.

Mapping HL7 CDA R2 Formatted Mass Screening Data to OpenEHR Archetypes.

Kobayashi S, Kume N, Yoshihara H.

Stud Health Technol Inform. 2017;245:1328.

PMID:
29295409
9.

Authenticating Unknown Doctors for Access to EHRs Based on Societal Trust.

Morris K, Kume N, Yamamoto G, Kobayashi S, Okamoto K, Tamura H, Kuroda T.

Stud Health Technol Inform. 2017;245:1308.

PMID:
29295391
10.

Privacy Policy Implementation on the Nation-Wide EHR in Japan for Hospitals and Patients.

Kume N, Kobayashi S, Araki K, Yoshihara H.

Stud Health Technol Inform. 2017;245:1305.

PMID:
29295388
11.

Generation of openEHR Test Datasets for Benchmarking.

El Helou S, Karvonen T, Yamamoto G, Kume N, Kobayashi S, Kondo E, Hiragi S, Okamoto K, Tamura H, Kuroda T.

Stud Health Technol Inform. 2017;245:1266.

PMID:
29295351
12.

Pharmacy Practice in Japan.

Nakagawa S, Kume N.

Can J Hosp Pharm. 2017 May-Jun;70(3):232-242. Epub 2017 Jun 30. No abstract available.

13.

Comparison of serum lipid management between elderly and non-elderly patients with and without coronary heart disease (CHD).

Shimizu R, Torii H, Yasuda D, Hiraoka Y, Furukawa Y, Yoshimoto A, Iwakura T, Matsuoka N, Tomii K, Kohara N, Hashida T, Kume N.

Prev Med Rep. 2016 Jun 8;4:192-8. doi: 10.1016/j.pmedr.2016.06.006. eCollection 2016 Dec.

14.

Matrix Metalloproteinase-9 as a Marker for Plaque Rupture and a Predictor of Adverse Clinical Outcome in Patients with Acute Coronary Syndrome: An Optical Coherence Tomography Study.

Kobayashi N, Takano M, Hata N, Kume N, Tsurumi M, Shirakabe A, Okazaki H, Shibuya J, Shiomura R, Nishigoori S, Seino Y, Shimizu W.

Cardiology. 2016;135(1):56-65. doi: 10.1159/000445994. Epub 2016 Jun 7.

PMID:
27271099
15.

Inter-polyelectrolyte nano-assembly induces folding and activation of functional peptides.

Shimada N, Kinoshita H, Tokunaga S, Umegae T, Kume N, Sakamoto W, Maruyama A.

J Control Release. 2015 Nov 28;218:45-52. doi: 10.1016/j.jconrel.2015.10.001. Epub 2015 Oct 3.

PMID:
26435456
16.

Development of Unified Lab Test Result Master for Multiple Facilities.

Kume N, Suzuki K, Kobayashi S, Araki K, Yoshihara H.

Stud Health Technol Inform. 2015;216:1050.

PMID:
26262349
17.
18.

Serum Lipid Goal Attainment in Chronic Kidney Disease (CKD) Patients under the Japan Atherosclerosis Society (JAS) 2012 Guidelines.

Shimizu R, Torii H, Yasuda D, Hiraoka Y, Kitada N, Hashida T, Yoshimoto A, Kita T, Kume N.

J Atheroscler Thromb. 2015;22(9):949-57. doi: 10.5551/jat.29165. Epub 2015 Apr 4.

19.

Plasma soluble lectin-like oxidized low-density lipoprotein receptor-1 as a novel prognostic biomarker in patients with ST-segment elevation acute myocardial infarction.

Higuma T, Abe N, Tateyama S, Endo T, Shibutani S, Yokoyama H, Hanada K, Yamada M, Tomita H, Hanada H, Osanai T, Kume N, Okumura K.

Circ J. 2015;79(3):641-8. doi: 10.1253/circj.CJ-14-0904. Epub 2015 Jan 23.

20.

Brassinosteroid-related transcription factor BIL1/BZR1 increases plant resistance to insect feeding.

Miyaji T, Yamagami A, Kume N, Sakuta M, Osada H, Asami T, Arimoto Y, Nakano T.

Biosci Biotechnol Biochem. 2014;78(6):960-8. doi: 10.1080/09168451.2014.910093. Epub 2014 Jun 26.

PMID:
25036120
21.

MicroRNA-33b knock-in mice for an intron of sterol regulatory element-binding factor 1 (Srebf1) exhibit reduced HDL-C in vivo.

Horie T, Nishino T, Baba O, Kuwabara Y, Nakao T, Nishiga M, Usami S, Izuhara M, Nakazeki F, Ide Y, Koyama S, Sowa N, Yahagi N, Shimano H, Nakamura T, Hasegawa K, Kume N, Yokode M, Kita T, Kimura T, Ono K.

Sci Rep. 2014 Jun 16;4:5312. doi: 10.1038/srep05312.

22.

MicroRNA-33 regulates sterol regulatory element-binding protein 1 expression in mice.

Horie T, Nishino T, Baba O, Kuwabara Y, Nakao T, Nishiga M, Usami S, Izuhara M, Sowa N, Yahagi N, Shimano H, Matsumura S, Inoue K, Marusawa H, Nakamura T, Hasegawa K, Kume N, Yokode M, Kita T, Kimura T, Ono K.

Nat Commun. 2013;4:2883. doi: 10.1038/ncomms3883.

23.

Tele-auscultation support system with mixed reality navigation.

Hori K, Uchida Y, Kan T, Minami M, Naito C, Kuroda T, Takahashi H, Ando M, Kawamura T, Kume N, Okamoto K, Takemura T, Yoshihara H.

Conf Proc IEEE Eng Med Biol Soc. 2013;2013:4646-9. doi: 10.1109/EMBC.2013.6610583.

PMID:
24110770
24.

Applying secret sharing for HIS backup exchange.

Kuroda T, Kimura E, Matsumura Y, Yamashita Y, Hiramatsu H, Kume N, Sato A.

Conf Proc IEEE Eng Med Biol Soc. 2013;2013:4179-82. doi: 10.1109/EMBC.2013.6610466.

PMID:
24110653
25.

The development of a multiplayer game for education of hospital management.

Takemura T, Tanaka T, Okamoto K, Kume N, Kuroda T, Hirose M, Yoshihara H.

Stud Health Technol Inform. 2013;192:1212.

PMID:
23920986
26.

Qualitative evaluation of the supporting system for diagnosis procedure combination code selection.

Okamoto K, Uchiyama T, Takemura T, Kume N, Adachi T, Kuroda T, Uchiyama T, Yoshihara H.

Stud Health Technol Inform. 2013;192:1031.

PMID:
23920805
27.

Simulating cloud environment for HIS backup using secret sharing.

Kuroda T, Kimura E, Matsumura Y, Yamashita Y, Hiramatsu H, Kume N.

Stud Health Technol Inform. 2013;192:171-4.

PMID:
23920538
28.

Development of a methodology for the detection of hospital financial outliers using information systems.

Okada S, Nagase K, Ito A, Ando F, Nakagawa Y, Okamoto K, Kume N, Takemura T, Kuroda T, Yoshihara H.

Int J Health Plann Manage. 2014 Jul-Sep;29(3):e207-32. doi: 10.1002/hpm.2194. Epub 2013 Jun 20.

PMID:
23785010
29.

Soluble lectin-like oxidized LDL receptor-1 (sLOX-1) as a valuable diagnostic marker for rupture of thin-cap fibroatheroma: verification by optical coherence tomography.

Kobayashi N, Takano M, Hata N, Kume N, Yamamoto M, Yokoyama S, Shinada T, Tomita K, Shirakabe A, Otsuka T, Seino Y, Mizuno K.

Int J Cardiol. 2013 Oct 9;168(4):3217-23. doi: 10.1016/j.ijcard.2013.04.110. Epub 2013 Apr 28.

PMID:
23632121
30.

Rupture progression model of stress integration for virtual reality ablation.

Kume N, Eguchi K, Kuroda T, Yoshimura K, Okubo K, Okamoto K, Takemura T, Yoshihara H.

Stud Health Technol Inform. 2013;184:242-6.

PMID:
23400164
31.

Impact of position tracking on the outpatient navigation system.

Kuroda T, Takemura T, Noma H, Okamoto K, Kume N, Yoshihara H.

Conf Proc IEEE Eng Med Biol Soc. 2012;2012:6104-6. doi: 10.1109/EMBC.2012.6347386.

PMID:
23367321
32.

MicroRNA-33 deficiency reduces the progression of atherosclerotic plaque in ApoE-/- mice.

Horie T, Baba O, Kuwabara Y, Chujo Y, Watanabe S, Kinoshita M, Horiguchi M, Nakamura T, Chonabayashi K, Hishizawa M, Hasegawa K, Kume N, Yokode M, Kita T, Kimura T, Ono K.

J Am Heart Assoc. 2012 Dec;1(6):e003376. doi: 10.1161/JAHA.112.003376. Epub 2012 Dec 19.

33.

Detection of acute aortic dissection by extremely high soluble lectin-like oxidized LDL receptor-1 (sLOX-1) and low troponin T levels in blood.

Kobayashi N, Hata N, Kume N, Yokoyama S, Takano M, Shinada T, Tomita K, Shirakabe A, Inami T, Seino Y, Mizuno K.

Int J Cardiol. 2013 May 25;165(3):557-9. doi: 10.1016/j.ijcard.2012.09.001. Epub 2012 Sep 26. No abstract available.

PMID:
23021597
34.

Hindered proton collectivity in 16(28)S12: possible magic number at Z=16.

Togano Y, Yamada Y, Iwasa N, Yamada K, Motobayashi T, Aoi N, Baba H, Bishop S, Cai X, Doornenbal P, Fang D, Furukawa T, Ieki K, Kawabata T, Kanno S, Kobayashi N, Kondo Y, Kuboki T, Kume N, Kurita K, Kurokawa M, Ma YG, Matsuo Y, Murakami H, Matsushita M, Nakamura T, Okada K, Ota S, Satou Y, Shimoura S, Shioda R, Tanaka KN, Takeuchi S, Tian W, Wang H, Wang J, Yoneda K.

Phys Rev Lett. 2012 Jun 1;108(22):222501. Epub 2012 May 29.

PMID:
23003590
35.

Lectin-like oxidized low-density lipoprotein receptor 1 signal is a potent biomarker and therapeutic target for human rheumatoid arthritis.

Ishikawa M, Ito H, Akiyoshi M, Kume N, Yoshitomi H, Mitsuoka H, Tanida S, Murata K, Shibuya H, Kasahara T, Kakino A, Fujita Y, Sawamura T, Yasuda T, Nakamura T.

Arthritis Rheum. 2012 Apr;64(4):1024-34. doi: 10.1002/art.33452. Epub 2011 Nov 10.

36.

Matrix metalloproteinase-9 for the earliest stage acute coronary syndrome.

Kobayashi N, Hata N, Kume N, Yokoyama S, Shinada T, Tomita K, Kitamura M, Shirakabe A, Inami T, Yamamoto M, Seino Y, Mizuno K.

Circ J. 2011;75(12):2853-61. Epub 2011 Oct 1.

37.

Soluble lectin-like oxidized LDL receptor-1 and high-sensitivity troponin T as diagnostic biomarkers for acute coronary syndrome. Improved values with combination usage in emergency rooms.

Kobayashi N, Hata N, Kume N, Shinada T, Tomita K, Shirakabe A, Kitamura M, Nozaki A, Inami T, Seino Y, Mizuno K.

Circ J. 2011;75(12):2862-71. Epub 2011 Sep 21.

38.

Pentraxin 3 as a biomarker for acute coronary syndrome: comparison with biomarkers for cardiac damage.

Kume N, Mitsuoka H, Hayashida K, Tanaka M.

J Cardiol. 2011 Jul;58(1):38-45. doi: 10.1016/j.jjcc.2011.03.006. Epub 2011 May 26.

39.

SR-PSOX/CXCL16 plays a critical role in the progression of colonic inflammation.

Uza N, Nakase H, Yamamoto S, Yoshino T, Takeda Y, Ueno S, Inoue S, Mikami S, Matsuura M, Shimaoka T, Kume N, Minami M, Yonehara S, Ikeuchi H, Chiba T.

Gut. 2011 Nov;60(11):1494-505. doi: 10.1136/gut.2010.221879. Epub 2011 Apr 6.

40.
41.

Development of fundamental infrastructure for nationwide EHR in Japan.

Takemura T, Araki K, Arita K, Suzuki T, Okamoto K, Kume N, Kuroda T, Takada A, Yoshihara H.

J Med Syst. 2012 Aug;36(4):2213-8. doi: 10.1007/s10916-011-9688-z. Epub 2011 Apr 1.

PMID:
21455698
42.

[SLOX-1 (soluble lectin-like oxidized low-density lipoprotein receptor-1)].

Kume N.

Nihon Rinsho. 2010 Jul;68 Suppl 7:859-61. Japanese. No abstract available.

PMID:
20960886
43.

Pitavastatin reduces elevated IL-18 levels in Japanese subjects with hypercholesterolemia: sub-analysis of Kansai investigation of statin for hyperlipidemic intervention in metabolism and endocrinology (KISHIMEN).

Fujioka Y, Fukuda A, Ishida T, Kagimoto S, Nakamura Y, Iwakura A, Hara K, Yamamoto T, Kuroe A, Ohya M, Fujimoto S, Hamamoto Y, Honjo S, Ikeda H, Nabe K, Tsuda K, Taniguchi A, Tanaka K, Koshiyama H, Kume N, Hirata K.

J Atheroscler Thromb. 2011;18(1):8-15. Epub 2010 Oct 6.

44.

Caloric restriction, aerobic exercise training and soluble lectin-like oxidized LDL receptor-1 levels in overweight and obese post-menopausal women.

Brinkley TE, Wang X, Kume N, Mitsuoka H, Nicklas BJ.

Int J Obes (Lond). 2011 Jun;35(6):793-9. doi: 10.1038/ijo.2010.199. Epub 2010 Sep 21.

45.

Soluble lectin-like oxidized LDL receptor-1 (sLOX-1) as a sensitive and specific biomarker for acute coronary syndrome--comparison with other biomarkers.

Kume N, Mitsuoka H, Hayashida K, Tanaka M, Kominami G, Kita T.

J Cardiol. 2010 Sep;56(2):159-65. doi: 10.1016/j.jjcc.2010.05.002. Epub 2010 Jun 1.

46.

Soluble lectin-like oxidized low-density lipoprotein receptor-1 predicts prognosis after acute coronary syndrome--a pilot study.

Kume N, Mitsuoka H, Hayashida K, Tanaka M, Kita T.

Circ J. 2010 Jul;74(7):1399-404. Epub 2010 May 14.

47.

Comparative analysis of the triplicate proathocyanidin regulators in Lotus japonicus.

Yoshida K, Kume N, Nakaya Y, Yamagami A, Nakano T, Sakuta M.

Plant Cell Physiol. 2010 Jun;51(6):912-22. doi: 10.1093/pcp/pcq067. Epub 2010 May 6.

PMID:
20448098
48.

[Molecular mechanisms of coronary atherosclerotic plaque formation and rupture].

Kume N.

Nihon Rinsho. 2010 Apr;68(4):637-41. Review. Japanese.

PMID:
20387554
49.

Pitavastatin decreases the expression of endothelial lipase both in vitro and in vivo.

Kojima Y, Ishida T, Sun L, Yasuda T, Toh R, Rikitake Y, Fukuda A, Kume N, Koshiyama H, Taniguchi A, Hirata K.

Cardiovasc Res. 2010 Jul 15;87(2):385-93. doi: 10.1093/cvr/cvp419. Epub 2010 Jan 2.

PMID:
20045866
50.

Circulating soluble SR-PSOX/CXCL16 as a biomarker for acute coronary syndrome -comparison with high-sensitivity C-reactive protein.

Mitsuoka H, Toyohara M, Kume N, Hayashida K, Jinnai T, Tanaka M, Kita T.

J Atheroscler Thromb. 2009 Oct;16(5):586-93. Epub 2009 Sep 3.

Supplemental Content

Support Center